Does Dr. MATTHEW ANASTASI have financial conflicts of interest?

Dr. MATTHEW ANASTASI (M.D.) has received a total of $258 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $258 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MATTHEW ANASTASI?

According to CMS Open Payments data, Dr. MATTHEW ANASTASI received funding from VERICEL CORPORATION ($124), FERRING PHARMACEUTICALS ($44), and BIOVENTUS ($36).

Does Dr. MATTHEW ANASTASI receive research grants or speaking fees?

Dr. MATTHEW ANASTASI has received $258 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MATTHEW ANASTASI

M.D.Real-Time Hydrated

Specialty: Family Medicine, Sports Medicine

Practice Location: SCOTTSDALE, AZ 85259

NPI Number: 1033353354

LIFETIME INDUSTRY VALUE

$258

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ANASTASI is a verified Family Medicine, Sports Medicine practitioner based in SCOTTSDALE, AZ.

Between 2021 and 2025, Dr. ANASTASI had an overall industry promotional and research financial footprint of $258 as recorded in the federal CMS Open Payments database.

$258 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ANASTASI's primary funding source is VERICEL CORPORATION, which accounts for $124 (representing 47.9% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

VERICEL CORPORATION

Rank 1

$124

47.9%

FERRING PHARMACEUTICALS

Rank 2

$44

16.9%

BIOVENTUS

Rank 3

$36

13.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.